All In Biotech

Drug Trial Radar · NCT00820534

A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers

A Randomised, Double-blind, Vehicle Controlled, Single Center, Parallel Group, Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers

Last checked: Nov 20, 2026Latest source record: Apr 20, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 126 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

126

Actual

Start

Dec 2008

Primary completion

Nov 2009

Study completion Nov 2009

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
First posted
Jan 12, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Comparison of the efficacy of penciclovir 10 mg/g (1%) cream with that of vehicle at 72 hours in preventing the appearance of classical lesions following prodromal symptoms (tingling or burning sensation) based on thermographic assessment among recurrent cold sore sufferers.

Conditions

  • Cold Sore

Interventions

  • PenciclovirDrug

    Penciclovir every 2 hours during waking hours for 96 hours

  • PlaceboDrug

    Placebo every 2 hous during waking hours for 96 hours

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Assessment Performed by the Investigator and Skin Temperature at the Cold Sore.Time frame: 72 hours

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Belfast Health and Social Care Trust, Royal Victoria Hospital

    Belfast, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.